January 20, 2025 07:46 AM EST
Financing
Startups

Sion­na and Odyssey end JPM week with IPO fil­ings

Kyle LaHucik

Senior Reporter

Sion­na Ther­a­peu­tics and Odyssey Ther­a­peu­tics have joined Met­sera and Maze in an at­tempt to go pub­lic via the still rocky IPO route.

The biotechs, fo­cused …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Sage sues Bio­gen days af­ter $469M buy­out of­fer

An­oth­er US biotech emerges with drug can­di­date from Chi­na-based Keymed

FDA ap­proves As­traZeneca and Dai­ichi Sankyo’s ADC for breast can­cer de­spite lack of sur­vival ben­e­fit

Ozem­pic makes list for next round of Medicare drug price ne­go­ti­a­tions

What Trump's CMS can and can't change with the sec­ond round of drug price ne­go­ti­a­tions

sponsored

Fu­el­ing More Break­throughs: Man­u­fac­tur­ing In­no­va­tion to Ex­pand Gene Ther­a­py’s Reach

A service from the Financial Times